Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease
worldwide. NAFLD stages range from simple steatosis (NAFL) to non-alcoholic …

Type 2 diabetes mellitus (T2DM) associated non-alcoholic fatty liver disease (NAFLD) is the
fourth-leading cause of death. Hyperglycemia induces various complications, including …

Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) are
increasingly relevant public health issues owing to their close association with the …

The accumulation of lipids is a histologic and biochemical hallmark of obesity-associated
nonalcoholic fatty liver disease (NAFLD). A subset of NALFD patients develops progressive …

Liver fibrosis is defined as excessive extracellular matrix deposition and is based on
complex interactions between matrix-producing hepatic stellate cells and an abundance of …

Inherited factors play a major role in the predisposition to nonalcoholic fatty liver disease
(NAFLD), and the rs738409 C→ G polymorphism of PNPLA3/adiponutrin, encoding for the …

Compelling evidence supports the concepts that gut microbiota actively promotes weight
gain and fat accumulation and sustains, indirectly, a condition of low-grade inflammation …

Liver regeneration is perhaps the most studied example of compensatory growth aimed to
replace loss of tissue in an organ. Hepatocytes, the main functional cells of the liver, manage …

Adipocyte death has been reported in both obese humans and rodents. However, its role in
metabolic disorders, including insulin resistance, hepatic steatosis, and inflammation …

Nonalcoholic fatty liver disease (NAFLD) is becoming a public health problem worldwide. A
subset of patients develop an inflammatory disease, nonalcoholic steatohepatitis (NASH) …